WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in CORT — Corcept Therapeutics Inc

CIK 1632972 PLYMOUTH, MN

Position in CORT

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$6,632,372

+$5,882,363 QoQ

Shares Held

76,278

+253.9% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 28 holders

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 47.58514906001731.ToString("F0")% Shared 0.ToString("F0")% None 52.41485093998269.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. CORT ranks #6 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc This page	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,632,372	76,278	+253.9%	Shares	Sole	2026-07-15
2025-12-31	$750,009	21,552	+3.9%	Shares	Sole	2026-01-08
2025-09-30	$1,724,449	20,749	+52.0%	Shares	Sole	2025-10-29
2025-06-30	$1,001,689	13,647	+71.6%	Shares	Sole	2025-07-10
2025-03-31	$908,505	7,954	+3.0%	Shares	Sole	2025-04-16
2024-12-31	$389,212	7,724	+50.1%	Shares	Sole	2025-03-17
2024-09-30	$238,156	5,146	—	Shares	Sole	2024-10-24
No filing history on record for this holder in this stock.